Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,399,335 papers from all fields of science
Search
Sign In
Create Free Account
X-Ray Exposure Time
Known as:
Exposure Time
The cumulative time a subject was exposed to X-rays.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
DICOM Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Depth of cure of LED vs QTH light-curing devices at a distance of 7 mm.
C. Ernst
,
Gerrit R Meyer
,
Julia Müller
,
E. Stender
,
M. O. Ahlers
,
Brita Willershausern
Journal of Adhesive Dentistry
2004
Corpus ID: 22302740
PURPOSE To determine the depth of cure of 5 blue LED curing devices compared to that obtained with 3 QTH curing devices…
Expand
Highly Cited
2001
Highly Cited
2001
A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution
L. Johansson
,
L. Johansson
,
A. Bjørnerud
,
H. Ahlström
,
D. Ladd
,
D. Fujii
Journal of Magnetic Resonance Imaging
2001
Corpus ID: 36771909
A preparation of ultra‐small superparamagnetic iron oxide (USPIO) particles coupled to an RGD peptide (RGD‐USPIO) was…
Expand
Highly Cited
1998
Highly Cited
1998
Near-Field Surface-Enhanced Raman Imaging of Dye-Labeled DNA with 100-nm Resolution.
Volker Deckert
,
and Dieter Zeisel
,
Renato Zenobi
,
Tuan Vo-Dinh
Analytical Chemistry
1998
Corpus ID: 10962368
Raman chemical imaging on a scale of 100 nm is demonstrated for the first time. This is made possible by the combination of…
Expand
Highly Cited
1996
Highly Cited
1996
Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells.
S. Boulton
,
S. Kyle
,
L. Yalcintepe
,
B. Durkacz
Carcinogenesis
1996
Corpus ID: 30451418
Wortmannin, an inhibitor of p110 PI 3-kinase, also inhibits DNA-dependent protein kinase, which is known to mediate DNA double…
Expand
Highly Cited
1991
Highly Cited
1991
Hardening of dual-cured cements under composite resin inlays.
Earl A. Hasegawa
,
Daniel B. Boyer
,
Daniel C. N. Chan
The Journal of prosthetic dentistry (Print)
1991
Corpus ID: 22196390
Highly Cited
1985
Highly Cited
1985
Improved hybridization assays employing tailed oligonucleotide probes: a direct comparison with 5'-end-labeled oligonucleotide probes and nick-translated plasmid probes.
M. Collins
,
W. Hunsaker
Analytical Biochemistry
1985
Corpus ID: 24840594
Highly Cited
1984
Highly Cited
1984
Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms.
A. Nichols
,
Christopher F Gabrieli
,
J. Fenoglio
,
Jr
,
P. Esser
,
Columbia
Circulation
1984
Corpus ID: 12232618
A computerized method for measuring relative coronary arterial stenosis by cinevideodensitometric analysis of 35 mm coronary…
Expand
Highly Cited
1976
Highly Cited
1976
The effect of adriamycin on the cell cycle traverse of a human lymphoid cell line.
B. Barlogie
,
B. Drewinko
,
Dennis A. Johnston
,
Emil J. Freireich
Cancer Research
1976
Corpus ID: 12775746
The kinetic response of a human lymphoma cell line to adriamycin was analyzed by means of pulse cytophotometry. Depending on…
Expand
Highly Cited
1965
Highly Cited
1965
Electron microscope and low-angle x-ray diffraction studies on outer segment membranes from the retina of the frog.
J. Blasie
,
Maynard M. Dewey
,
Allen E. Blaurock
,
C. R. Worthington
Journal of Molecular Biology
1965
Corpus ID: 38469846
Highly Cited
1961
Highly Cited
1961
DEMONSTRATION OF MOUSE ISOANTIGENS AT THE CELLULAR LEVEL BY THE FLUORESCENT ANTIBODY TECHNIQUE
G. Möller
Journal of Experimental Medicine
1961
Corpus ID: 15165990
The fluorescent antibody technique has been applied for the demonstration of mouse isoantigens at the cellular level. Specific…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE